Hybrid argon plasma coagulation: a new modality for treatment of a diffuse foregut anastomotic dysplastic lesion Truptesh H. Kothari, MD, Shivangi Kothari, MD, Vivek Kaul, MD Endoscopic management of a diffusely spreading adenomatous/dysplastic lesion at the site of a gastrojejunostomy (GJ) anastomosis can be challenging. EMR and endoscopic submucosal dissection (ESD) are technically difficult at such locations, and there is a risk of incomplete resection. We present a case of endoscopic management of such a lesion in an elderly patient using the novel hybrid argon plasma coagulation (APC) technology (Video 1, available online at www.VideoGIE.org).
A 91-year-old man with a history of Roux-en-Y GJ for gastric bypass was referred for further management of a diffusely spreading dysplastic lesion at the GJ anastomosis (Fig. 1) . Hybrid APC was used with 30 bars (435 psi) for injection with the probe at the base of the lesion. After optimal lift of the mucosal area at the lesion site, APC was performed at 60 W pulsed 2 for ablation. The treated area was then removed by use of the mucosal scraping technique with a soft cap attached to the distal end of the gastroscope. Repeated injection-APC was performed to the newly exposed tissue base (Fig. 2) . The patient was admitted overnight for observation and was discharged the next day.
Repeated endoscopy and biopsy sampling at 3-month and 6-month surveillance intervals after treatment revealed normal nondysplastic mucosa (Fig. 3) . The biopsy specimens were obtained from the site of the original lesion. Examination was performed under narrow-band imaging and white light.
We conclude that hybrid APC is a novel therapeutic tool for the management of diffusely spreading dysplastic lesions in difficult locations where EMR and ESD are technically challenging.
